Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 2 Study of PH-10 for the Treatment of Atopic Dermatitis

This study has been completed.
Information provided by:
Provectus Pharmaceuticals Identifier:
First received: June 3, 2008
Last updated: September 24, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)